n-methylaspartate has been researched along with pirenzepine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvet, GA; Ventura, AL | 1 |
| Aceves, J; Arias-Montaño, JA; Young, JM | 1 |
| Duhan, NL; Farber, NB; Foster, J; Olney, JW | 1 |
| Semba, K; White, TD | 1 |
| Moore, N | 1 |
| Breier, A | 1 |
| Arvanov, V; Jardemark, KE; Liang, X; Wang, RY | 1 |
| Jardemark, KE; Ninan, I; Wang, RY | 1 |
| Coutureau, E; Di Scala, G; Esclassan, F; Marchand, AR | 1 |
| Bertacchini, GL; da Silva, LA; da Silva-Júnior, AF; Diniz, CRAF; Resstel, LBM; Uliana, DL | 1 |
2 review(s) available for n-methylaspartate and pirenzepine
| Article | Year |
|---|---|
[Olanzapine: preclinical pharmacology and recent findings].
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; N-Methylaspartate; Olanzapine; Pirenzepine; Pyramidal Tracts; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Muscarinic; Receptors, Serotonin | 1998 |
Cognitive deficit in schizophrenia and its neurochemical basis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Glutamic Acid; Haloperidol; Humans; N-Methylaspartate; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology | 1999 |
8 other study(ies) available for n-methylaspartate and pirenzepine
| Article | Year |
|---|---|
Accumulation of 3H-phosphoinositides mediated by muscarinic receptors in the developing chick retina: inhibition of carbachol-induced response by glutamate receptors.
Topics: Animals; Atropine; Carbachol; Chick Embryo; Glutamic Acid; In Vitro Techniques; N-Methylaspartate; Phosphatidylinositols; Physostigmine; Pirenzepine; Receptors, Glutamate; Receptors, Muscarinic; Retina | 1995 |
Carbachol-induced phosphoinositide metabolism in slices of rat substantia nigra pars reticulata.
Topics: Animals; Carbachol; Hydrolysis; In Vitro Techniques; Male; Micromanipulation; N-Methylaspartate; Phosphatidylinositols; Pirenzepine; Rats; Rats, Wistar; Receptors, Muscarinic; Substantia Nigra | 1993 |
Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzazepines; Dibenzoxazepines; Dizocilpine Maleate; Female; N-Methylaspartate; Nervous System; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1996 |
M3 muscarinic receptor-mediated enhancement of NMDA-evoked adenosine release in rat cortical slices in vitro.
Topics: Adenosine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Atropine; Carbachol; Cerebral Cortex; Diamines; Drug Synergism; In Vitro Techniques; Kinetics; Magnesium; Male; Muscarinic Agonists; Muscarinic Antagonists; N-Methylaspartate; Piperidines; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M3; Receptors, Muscarinic | 1997 |
Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Synergism; Electrophysiology; Excitatory Amino Acid Agonists; Haloperidol; In Vitro Techniques; Male; N-Methylaspartate; Olanzapine; Pharmaceutical Vehicles; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Time Factors | 2000 |
Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Haloperidol; Male; Membrane Potentials; N-Methylaspartate; Olanzapine; Patch-Clamp Techniques; Phencyclidine; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2003 |
A cholinergic-dependent role for the entorhinal cortex in trace fear conditioning.
Topics: Acetylcholine; Acoustic Stimulation; Animals; Association Learning; Conditioning, Classical; Dose-Response Relationship, Drug; Electroshock; Entorhinal Cortex; Excitatory Amino Acid Agonists; Fear; Immunohistochemistry; Immunotoxins; Male; Microinjections; Muscarinic Antagonists; N-Methylaspartate; Pirenzepine; Rats; Rats, Long-Evans; Reaction Time; Receptor, Muscarinic M1; Reflex, Startle; Ribosome Inactivating Proteins, Type 1; Saporins | 2009 |
The interaction between hippocampal cholinergic and nitrergic neurotransmission coordinates NMDA-dependent behavior and autonomic changes induced by contextual fear retrieval.
Topics: Acetylcholine; Animals; Cholinergic Agents; Fear; Fumarates; Guanosine Monophosphate; Guanylate Cyclase; Hippocampus; Male; N-Methylaspartate; Neostigmine; Nitric Oxide; Nitric Oxide Synthase Type I; Pirenzepine; Rats; Rats, Wistar; Receptors, Cholinergic; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2022 |